We're building a meditation app that also happens to be an email client :)

The sheer scale of a trillion dollars can be hard to comprehend. Let me put it in perspective. You would be able to buy 42 miles of high speed rail in California with that much money.

React Native and @expo are the best way to build apps with AI, and if you want to know why, @ccheever's keynote from this year's App.js Conf is a must-watch: youtube.com/watch?v=605Id2fh…

Internally at @linear, the agent created and merged 700 PRs last month. Often fixing bugs automatically from triage.

I just tried @linear Diff. Genuinely speechless. The UI is so fucking good. Everything flows, it's beautiful, the AI makes sense, this is ridiculously perfect. I've been staring at it for 10 minutes, just appreciating how well it's designed

this is as close to a todo list that to-does itself, that i’ve seen yet

I’ve been working on this at Linear for the past few months. You can now tell the Linear agent to create and work on an issue, or manually delegate to it yourself. Coding is done within a secure sandbox, which spins up fast. Ask for follow-ups inside of diffs, all without leaving Linear. Lots of improvements to come, let me know what you want to see :)

Introducing coding sessions. Linear Agent can now triage issues, investigate the cause, write the fix, open a PR, and bring the code back for review. All shared with your team in Linear.

We're launching Bridge today 🌉 An AI engine that builds virtual homes. Blueprint in, walkable home out. Every plan, every option, structural changes included. What took 3D artists months now takes days. Homebuilders can finally show buyers every home they sell. arcway.ai

I’ve been both the bullied and the bully, the guy who came through in a pinch and the guy who bombed it, the cheater and the cheatee, the groveling outsider minority and the smug elite incumbent. Developing a theory of mind of everyone you meet (particularly when they can’t do the reverse) is a superpower.

If the key to becoming a billionaire is to exploit people, as some politicians claim, we at YC are idiots. We've spent the last 20 years choosing the wrong founders and teaching them the wrong things. Or maybe we do actually understand startups, and the politicians are wrong.

Played the hell out of this guy’s video games growing up. Total fanboy moment meeting @HIDEO_KOJIMA_EN in NYC

Linear always raises the design bar with every new product they offer Absolute best in the game 🔥

With NewLimit tripling in value, it looks like Brian Armstrong joins a very small club of founders who have built multiple unicorns

Stablecoins are going mainstream.

we've been quietly building @typedotcom. today we're sharing it with the world. type is the first multiplayer ai product for marketing, sales, support, coding, and much more. create ai teammates that work with all your tools and everyone at your company.

I love Bitcoin but I wish the community could have more rational discussions about current headwinds Namely: Quantum risk and Michael Saylor The market needs to regain confidence around both of those risks before Bitcoin can be rightfully viewed as a long-term asset

Team Docs beta for @linear. One of our most requested features In this video, I continue the journey and show how we use Linear, Figma, and Slack to build these features how Team Docs & Home works. If you want to try it, reply with your workspace name

This has quietly been a miracle month in medicine. In the last 5 weeks we’ve got news on: - retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels - RevMed’s new pancreatic cancer drug showing unprecedented abilities to extend life - small trial of a one-and-done PCSK9 gene editing therapy for slashing LDL cholesterol - Mayo’s AI-assisted radiology showing vastly improved cancer detection - this new therapy for metastatic solid tumors This stuff is at varying levels of evidence. Retatrutide is ~100% on its way, other stuff needs more clinical trial data. But put it together and we’re maybe on the verge of majorly reducing the mortality of heart disease and cancer, the two leading causes of death in America.